Qualitative and Quantitative Prediction of Blood-Brain Barrier Permeability of Chemicals via an SE(3)-Transformer-Based Model with LLM-Assisted Explanation.
Aug 2026· Environmental Science and Technology· Vol 60 32, pp.
22653-22664
· 0 citations· 67 references
Medicine
TL;DR
A multifeature fusion framework for identifying and quantifying the BBB permeability to neurotoxic chemicals, which leverages an SE(3)-Transformer to encode the three-dimensional molecular geometry and a deep neural network to encode collision cross-section and fingerprint.
Abstract
The blood-brain barrier (BBB) regulates the entry of chemicals into the central nervous system, and contaminants with high permeability can accumulate in the brain, posing neurotoxicity risks. Given the urgent need for high-throughput neurotoxicity assessment, this study proposes a multifeature fusion framework for identifying and quantifying the BBB permeability to neurotoxic chemicals. BBBProfiler leverages an SE(3)-Transformer to encode the three-dimensional molecular geometry and a deep neural network to encode collision cross-section (CCS) and fingerprint, followed by adaptive integration of modality representations through gating weights. Under the scaffold-split evaluation, BBBProfiler achieves high performance with an area under the receiver operating characteristic curve (AUC) of 93.72% and a recall of 89.19% for classification, and a coefficient of determination (R2) of 0.72 for regression. Its predictive performance was validated using a BBB bioassay (11 chemicals) and an external data set (2023 chemicals), in which the model achieved 94.42% AUC. Substructure mask explanation analysis revealed CCS as an influential feature that correlated well with BBB permeability to chemicals (R2 = 0.84). Model predictions were supplemented with natural-language explanations generated from a large language model. BBBProfiler is deployed on a publicly accessible platform (https://www.ai4environ.cn/BBBProfiler) to facilitate the development of new approach methodologies for neurotoxicity evaluation.
A next generation CNS-MPO framework, Aragen-iMPO, (A-iMPO) is introduced which was developed using 5,129 curated compounds through an integrated workflow combining explainable machine learning, rigorous descriptor selection, and low-dimensional discriminant mapping.
S. Phukan, Ashis Nandy, M. Ramarao· ACS Medicinal Chemistry Lett...· 0 citations
Blood-brain barrier (BBB) permeability is a critical determinant in the development of central nervous system therapeutics because it directly influences the ability of drug candidates to reach their target sites within the brain. In this study, an explainable machine learning framework was developed to predict BBB per...
BACKGROUND
Predicting blood-brain barrier (BBB) permeability remains a central problem in central nervous system (CNS) drug design. Conventional rules such as Lipinski's rule of five and related CNS guidelines describe physicochemical boundaries but do not guarantee permeability.
OBJECTIVE
We examined how a set of mo...
Tatsuki Onishi· European Journal of Pharmace...· 0 citations
Evidence that LogP-BBB associations vary systematically across chemical space is insufficient underscores that feature representation and model architecture are coupled design choices, and that unorthogonalized causal forests risk overstating genuine treatment effect heterogeneity.
Tshemollo Rapolai, S. Makgai, Mohammad Arashi· 0 citations
Background/Objectives: Blood–brain barrier (BBB) permeability prediction is important for central nervous system drug discovery. Many models rely mainly on chemical structure, omit transport information, and may report optimistic performance when related compounds occur across training and test sets without adequate le...
Yu Shin, Sahith Mada, S. Dakshanamurthy· Pharmaceuticals· 0 citations
Blood-brain barrier (BBB) permeability of drugs is fundamental to understand yet incredibly difficult to measure, or even, predict. This study proposes the adoption of a chemically modified form of poly(dimethylsiloxane) (PDMS) as an in vitro biomedical mimic of the BBB for pharmaceutical analysis. Initially, a series...
Laura J Waters, Shaizah Tahir, Joseph Whiteley· Analytical Methods· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.